Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
709 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tohoku University School of Medicine
Sendai, Aoba-ku, Japan
- Kure Medical Center and Chugoku Cancer Center
Kure, Hiroshima, Japan
- Hokkaido University Hospital
Sapporo, Hokkaido, Japan
- Iwate Medical University Hospital
Shiwa-gun, Iwate, Japan
- Kagoshima City Hospital
Kagoshima, Kagoshima-ken, Japan
- Niigata University Medical and Dental Hospital
Niigata, Niigata, Japan
- Shizuoka Cancer Center
Shizuoka, Suntou, Japan
- Keio University
Shinjuku-ku, Tokyo, Japan
- Hiroshima University Hospital
Hiroshima, Japan
- Shikoku Cancer Center
Matsuyama, Japan
- National Kyushu Cancer Center
Minamiku, Japan
- Jikei University School of Medicine
Minato-ku, Tokyo, Japan
- Kindai University
Osaka, Japan
- Saitama Medical University International Medical Center
Saitama, Japan
- National Cancer Center Hospital
Tokyo, Japan
- Tottori University
Tottori, Japan
- Keimyung University-Dongsan Medical Center
Dalseo-gu, Daegu, South Korea
- National Cancer Center-Korea
Goyang-si, Gyeonggi-do, South Korea
- Catholic University of Korea-Seoul Saint Mary'S Hospital
Seoul, Korea, South Korea
- Samsung Medical Center
Seoul, Korea, South Korea
- Seoul National University Bundang Hospital
Seongnam, Kyeonggi-do, South Korea
- Gachon University Gil Hospital
Incheon, South Korea
- Asan Medical Center
Seoul, South Korea
- Ewha Woman'S University
Seoul, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- Korea Cancer Center Hospital
Seoul, South Korea
- Kyung Hee University Hospital at Gangdong
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Ajou University Hospital
Suwon, South Korea
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Dec 2007
- Primary completion
- 30 Apr 2019
- Completion
- 1 Jan 2028
- Last update posted
- 30 Dec 2025
- Registered enrollment
- 1,052
- Registry id
- NCT00565851
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.